Fig. 1: Outcome after landmark (d + 28) of the training cohort (all patients, including those with SOS/VOD).
From: Early bilirubinemia after allogeneic stem cell transplantation—an endothelial complication
EB early bilirubinemia ≥3.6 mg/dL between days 0 and 28; SOS/VOD sinusoidal obstruction syndrome/veno-occlusive disease, none, no SOS/VOD and bilirubin <3.6 mg/dl; OS overall survival, NRM non-relapse mortality, TTR time to relapse.
